Nachrichten zur Ligand Pharmaceuticals Aktie

Ligand (LGND) Q3 2025 Earnings Call Transcript

Image source: The Motley Fool.DATEThursday, Nov. 6, 2025, at 8:30 a.m. ETCALL PARTICIPANTSChief Executive Officer — Todd DavisChief Financial Officer…

Ligand Pharmaceuticals stock hits 52-week high at 186.46 USD By Investing.com

Ligand Pharmaceuticals stock hits 52-week high at 186.46 USD…

Ligand Pharmaceuticals unterstreicht Resilienz im Biotech-Sektor

Ligand Pharmaceuticals ist ein US-Biopharmaunternehmen mit Sitz in Jupiter (Florida), das sich auf ein Lizenz- und Royalty-Modell spezialisiert hat: Anstatt…

Ligand Pharmaceuticals: Attractive Royalty Model Powers Forward

…

Ligand Pharmaceuticals: Buy This Strong Growing Pharma And Get A Stake In Dozens Of Therapies

…

Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial Officer

Mr. Korenberg is a seasoned executive with significant operational and financial leadership experience, including senior roles at Ligand Pharmaceuticals (NASDAQ:…

invIOs raises €8.2 million in a Series A to finance pipeline progress in immuno-oncology

VIENNA, Oct. 15, 2024 (GLOBE NEWSWIRE) -- invIOs GmbH (“invIOs”), a privately held biotechnology company developing novel therapies…

Ligand Pharmaceuticals Incorporated 2024 Q2 - Results - Earnings Call Presentation

…

Ligand Pharmaceuticals reports mixed Q2 results; reaffirms FY24 outlook

…

Ligand Pharmaceuticals: Solid Performer Performing Solidly

…

Ligand (LGND) Beats Q1 Earnings, Misses Sales Estimates

Ligand Pharmaceuticals (LGND) reports mixed first-quarter results. Management reiterates the 2024 financial outlook.…

Ligand Pharmaceuticals Incorporated 2024 Q1 - Results - Earnings Call Presentation

…

Ligand (LGND) Q4 Earnings Surpass Estimates, Stock Surges

Ligand Pharmaceuticals (LGND) reports encouraging fourth-quarter results as earnings and sales beat estimates. Management reiterates the 2024 financial outlook.…

dpa-AFX ProFeed